share_log
Reuters ·  Jan 10 12:02
Bio Path Holdings Inc: In 2025, Expects to Complete Preclinical Testing of Prexigebersen and to File an Ind
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 360

Recommended

Write a comment